PedsQL 3.2 Diabetes module for children, adolescents, and young adults: Reliability and validity in type 1 diabetes

James W. Varni*, Alan M. Delamater, Korey K. Hood, Jennifer K. Raymond, Nancy T. Chang, Kimberly A. Driscoll, Jenise C. Wong, Joyce P. Yi-Frazier, Ellen K. Grishman, Melissa A. Faith, Sarah D. Corathers, Jessica C. Kichler, Jennifer L. Miller, Elena M. Doskey, Robert W. Heffer, Don P. Wilson

*Corresponding author for this work

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

OBJECTIVE: The objective of the study was to report on the measurement properties of the revised and updated Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for children, adolescents, and young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The 33-item PedsQL 3.2 Diabetes Module and PedsQL Generic Core Scales were completed in a 10-site national field test study by 656 families of patients ages 2-25 years with type 1 diabetes. RESULTS: The 15-item Diabetes Symptoms Summary Score and 18-item Diabetes Management Summary Score were derived from the factor analysis of the items. The Diabetes Symptoms and Diabetes Management Summary Scores evidenced excellent reliability (patient self-report a = 0.88-0.90; parent proxy report a = 0.89-0.90). The Diabetes Symptoms and Diabetes Management Summary Scores demonstrated construct validity through medium to large effect size correlations with the Generic Core Scales Total Scale Score (r = 0.43-0.67, P < 0.001). HbA1c was significantly correlated with the Diabetes Symptoms and Diabetes Management Summary Scores (r = 20.21 to 20.29, P < 0.001). Minimal clinically important difference scores ranged from 5.05 to 5.55. CONCLUSIONS: The PedsQL 3.2 Diabetes Module Diabetes Symptoms and Diabetes Management Summary Scores demonstrated excellent measurement properties and may be useful as standardized patient-reported outcomes of diabetes symptoms and diabetes management in clinical research, clinical trials, and practice in children, adolescents, and young adults with type 1 diabetes.

Original languageEnglish (US)
Pages (from-to)2064-2071
Number of pages8
JournalDiabetes care
Volume41
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Type 1 Diabetes Mellitus
Reproducibility of Results
Young Adult
Proxy
Self Report
Statistical Factor Analysis
Research Design
Quality of Life
Clinical Trials
Pediatrics
Equipment and Supplies
Research

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Varni, J. W., Delamater, A. M., Hood, K. K., Raymond, J. K., Chang, N. T., Driscoll, K. A., ... Wilson, D. P. (2018). PedsQL 3.2 Diabetes module for children, adolescents, and young adults: Reliability and validity in type 1 diabetes. Diabetes care, 41(10), 2064-2071. https://doi.org/10.2337/dc17-2707
Varni, James W. ; Delamater, Alan M. ; Hood, Korey K. ; Raymond, Jennifer K. ; Chang, Nancy T. ; Driscoll, Kimberly A. ; Wong, Jenise C. ; Yi-Frazier, Joyce P. ; Grishman, Ellen K. ; Faith, Melissa A. ; Corathers, Sarah D. ; Kichler, Jessica C. ; Miller, Jennifer L. ; Doskey, Elena M. ; Heffer, Robert W. ; Wilson, Don P. / PedsQL 3.2 Diabetes module for children, adolescents, and young adults : Reliability and validity in type 1 diabetes. In: Diabetes care. 2018 ; Vol. 41, No. 10. pp. 2064-2071.
@article{164f45140ac34963a67fe9e9bb393fbd,
title = "PedsQL 3.2 Diabetes module for children, adolescents, and young adults: Reliability and validity in type 1 diabetes",
abstract = "OBJECTIVE: The objective of the study was to report on the measurement properties of the revised and updated Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for children, adolescents, and young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The 33-item PedsQL 3.2 Diabetes Module and PedsQL Generic Core Scales were completed in a 10-site national field test study by 656 families of patients ages 2-25 years with type 1 diabetes. RESULTS: The 15-item Diabetes Symptoms Summary Score and 18-item Diabetes Management Summary Score were derived from the factor analysis of the items. The Diabetes Symptoms and Diabetes Management Summary Scores evidenced excellent reliability (patient self-report a = 0.88-0.90; parent proxy report a = 0.89-0.90). The Diabetes Symptoms and Diabetes Management Summary Scores demonstrated construct validity through medium to large effect size correlations with the Generic Core Scales Total Scale Score (r = 0.43-0.67, P < 0.001). HbA1c was significantly correlated with the Diabetes Symptoms and Diabetes Management Summary Scores (r = 20.21 to 20.29, P < 0.001). Minimal clinically important difference scores ranged from 5.05 to 5.55. CONCLUSIONS: The PedsQL 3.2 Diabetes Module Diabetes Symptoms and Diabetes Management Summary Scores demonstrated excellent measurement properties and may be useful as standardized patient-reported outcomes of diabetes symptoms and diabetes management in clinical research, clinical trials, and practice in children, adolescents, and young adults with type 1 diabetes.",
author = "Varni, {James W.} and Delamater, {Alan M.} and Hood, {Korey K.} and Raymond, {Jennifer K.} and Chang, {Nancy T.} and Driscoll, {Kimberly A.} and Wong, {Jenise C.} and Yi-Frazier, {Joyce P.} and Grishman, {Ellen K.} and Faith, {Melissa A.} and Corathers, {Sarah D.} and Kichler, {Jessica C.} and Miller, {Jennifer L.} and Doskey, {Elena M.} and Heffer, {Robert W.} and Wilson, {Don P.}",
year = "2018",
month = "10",
day = "1",
doi = "10.2337/dc17-2707",
language = "English (US)",
volume = "41",
pages = "2064--2071",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "10",

}

Varni, JW, Delamater, AM, Hood, KK, Raymond, JK, Chang, NT, Driscoll, KA, Wong, JC, Yi-Frazier, JP, Grishman, EK, Faith, MA, Corathers, SD, Kichler, JC, Miller, JL, Doskey, EM, Heffer, RW & Wilson, DP 2018, 'PedsQL 3.2 Diabetes module for children, adolescents, and young adults: Reliability and validity in type 1 diabetes', Diabetes care, vol. 41, no. 10, pp. 2064-2071. https://doi.org/10.2337/dc17-2707

PedsQL 3.2 Diabetes module for children, adolescents, and young adults : Reliability and validity in type 1 diabetes. / Varni, James W.; Delamater, Alan M.; Hood, Korey K.; Raymond, Jennifer K.; Chang, Nancy T.; Driscoll, Kimberly A.; Wong, Jenise C.; Yi-Frazier, Joyce P.; Grishman, Ellen K.; Faith, Melissa A.; Corathers, Sarah D.; Kichler, Jessica C.; Miller, Jennifer L.; Doskey, Elena M.; Heffer, Robert W.; Wilson, Don P.

In: Diabetes care, Vol. 41, No. 10, 01.10.2018, p. 2064-2071.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PedsQL 3.2 Diabetes module for children, adolescents, and young adults

T2 - Reliability and validity in type 1 diabetes

AU - Varni, James W.

AU - Delamater, Alan M.

AU - Hood, Korey K.

AU - Raymond, Jennifer K.

AU - Chang, Nancy T.

AU - Driscoll, Kimberly A.

AU - Wong, Jenise C.

AU - Yi-Frazier, Joyce P.

AU - Grishman, Ellen K.

AU - Faith, Melissa A.

AU - Corathers, Sarah D.

AU - Kichler, Jessica C.

AU - Miller, Jennifer L.

AU - Doskey, Elena M.

AU - Heffer, Robert W.

AU - Wilson, Don P.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - OBJECTIVE: The objective of the study was to report on the measurement properties of the revised and updated Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for children, adolescents, and young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The 33-item PedsQL 3.2 Diabetes Module and PedsQL Generic Core Scales were completed in a 10-site national field test study by 656 families of patients ages 2-25 years with type 1 diabetes. RESULTS: The 15-item Diabetes Symptoms Summary Score and 18-item Diabetes Management Summary Score were derived from the factor analysis of the items. The Diabetes Symptoms and Diabetes Management Summary Scores evidenced excellent reliability (patient self-report a = 0.88-0.90; parent proxy report a = 0.89-0.90). The Diabetes Symptoms and Diabetes Management Summary Scores demonstrated construct validity through medium to large effect size correlations with the Generic Core Scales Total Scale Score (r = 0.43-0.67, P < 0.001). HbA1c was significantly correlated with the Diabetes Symptoms and Diabetes Management Summary Scores (r = 20.21 to 20.29, P < 0.001). Minimal clinically important difference scores ranged from 5.05 to 5.55. CONCLUSIONS: The PedsQL 3.2 Diabetes Module Diabetes Symptoms and Diabetes Management Summary Scores demonstrated excellent measurement properties and may be useful as standardized patient-reported outcomes of diabetes symptoms and diabetes management in clinical research, clinical trials, and practice in children, adolescents, and young adults with type 1 diabetes.

AB - OBJECTIVE: The objective of the study was to report on the measurement properties of the revised and updated Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for children, adolescents, and young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The 33-item PedsQL 3.2 Diabetes Module and PedsQL Generic Core Scales were completed in a 10-site national field test study by 656 families of patients ages 2-25 years with type 1 diabetes. RESULTS: The 15-item Diabetes Symptoms Summary Score and 18-item Diabetes Management Summary Score were derived from the factor analysis of the items. The Diabetes Symptoms and Diabetes Management Summary Scores evidenced excellent reliability (patient self-report a = 0.88-0.90; parent proxy report a = 0.89-0.90). The Diabetes Symptoms and Diabetes Management Summary Scores demonstrated construct validity through medium to large effect size correlations with the Generic Core Scales Total Scale Score (r = 0.43-0.67, P < 0.001). HbA1c was significantly correlated with the Diabetes Symptoms and Diabetes Management Summary Scores (r = 20.21 to 20.29, P < 0.001). Minimal clinically important difference scores ranged from 5.05 to 5.55. CONCLUSIONS: The PedsQL 3.2 Diabetes Module Diabetes Symptoms and Diabetes Management Summary Scores demonstrated excellent measurement properties and may be useful as standardized patient-reported outcomes of diabetes symptoms and diabetes management in clinical research, clinical trials, and practice in children, adolescents, and young adults with type 1 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=85054301571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054301571&partnerID=8YFLogxK

U2 - 10.2337/dc17-2707

DO - 10.2337/dc17-2707

M3 - Article

C2 - 30061317

AN - SCOPUS:85054301571

VL - 41

SP - 2064

EP - 2071

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 10

ER -